The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group
Ryan J. Beechinor(University of North Carolina at Chapel Hill), Daniel González(University of North Carolina at Chapel Hill), ZoAnn E. Dreyer(Baylor College of Medicine), Jacqueline G. Gerhart(University of North Carolina at Chapel Hill), Ryan Vargo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lisa Bomgaars(Stollery Children's Hospital), Patrick A. Thompson(University of North Carolina at Chapel Hill), Michael F. Hwang(University of North Carolina at Chapel Hill)
Cited by 39
Related Papers
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2006|309
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
|Clinical Therapeutics|2016|170